Literature DB >> 19666667

Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part).

Tilman B Drüeke1, Malik Touam.   

Abstract

The debate on the most adequate dialysate calcium concentration for intermittent haemodialysis therapy is ongoing. There is probably no one optimal concentration. In general, one would like to maintain a neutral calcium balance in adult haemodialysis patients. However, a slightly negative balance may be preferable to avoid soft-tissue calcium accumulation in face of net calcium loss from the bone with ageing. The problem with measurements of calcium balance is that they are generally imprecise, as are estimations of total body calcium and its distribution in various compartments, unless done with labour-intensive methods and great care. The choice of the dialysate calcium will depend on several factors, including parathyroid and vitamin D status, type and severity of concomitant bone disease, presence or absence of arterial calcification, dietary habits, drug treatment and dialysis modality. Ideally the dialysate calcium would be adapted to each patient's needs. This is not feasible, however, in most dialysis settings and neither is it cost-effective. From a practical point of view, a relatively high dialysate calcium concentration in the range of of 1.50-1.75 mmol/L (3.0-3.5 mEq/L) should probably be preferred in haemodialysis patients with high serum PTH levels who are not prescribed calcium-based phosphate binders or high doses of active vitamin D sterols, and in those who are receiving a calcimimetic. In those who are treated with high doses of calcium-based binders and/or active vitamin D derivatives or who have a very low serum PTH level, the optimal dialysate calcium concentration is probably lower, in the range of 1.25-1.50 mmol/L (2.50-3.0 mEq/L). In the present pro/con debate about the optimal dialysate calcium concentration used for the haemodialysis session, we have accepted to defend the viewpoint that a low calcium concentration may do more harm than benefit in many patients. This viewpoint is opposite to that taken by Gotch. He argues that since calcitriol and other active vitamin D derivatives have become available virtually all haemodialysis patients are in positive calcium balance. We would like to take issue with this statement and warn against the indiscriminate use of a low calcium dialysate in all patients receiving haemodialysis therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666667     DOI: 10.1093/ndt/gfp365

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Low calcium dialysate combined with CaCO3 in hyperphosphatemia in hemodialysis patients.

Authors:  Zhuo Gao; Li-DE Lun; Xin-Lun Li
Journal:  Exp Ther Med       Date:  2013-04-17       Impact factor: 2.447

2.  Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges.

Authors:  Jakob Gubensek; Alesa Orsag; Rafael Ponikvar; Jadranka Buturovic-Ponikvar
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

3.  Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis.

Authors:  Mineaki Kitamura; Yohei Tateishi; Shuntaro Sato; Satoko Kitamura; Yuki Ota; Kumiko Muta; Hiroshi Yamashita; Tadashi Uramatsu; Yoko Obata; Yasushi Mochizuki; Masaharu Nishikido; Tsuyoshi Izumo; Takashi Harada; Satoshi Funakoshi; Takayuki Matsuo; Akira Tsujino; Hideki Sakai; Hiroshi Mukae; Tomoya Nishino
Journal:  BMC Nephrol       Date:  2019-06-07       Impact factor: 2.388

4.  Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial.

Authors:  Kunitoshi Iseki; Daijiro Kabata; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto; Katsuhito Mori; Tomoaki Morioka; Shinya Nakatani; Ayumi Shintani
Journal:  PLoS One       Date:  2022-09-07       Impact factor: 3.752

5.  Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH.

Authors:  Takahiro Kuragano; Minoru Furuta; Mana Yahiro; Aritoshi Kida; Yoshinaga Otaki; Yukiko Hasuike; Akihide Matsumoto; Takeshi Nakanishi
Journal:  BMC Nephrol       Date:  2013-01-18       Impact factor: 2.388

Review 6.  Optimizing haemodialysate composition.

Authors:  Francesco Locatelli; Vincenzo La Milia; Leano Violo; Lucia Del Vecchio; Salvatore Di Filippo
Journal:  Clin Kidney J       Date:  2015-08-08

7.  Quantification of Dialytic Removal and Extracellular Calcium Mass Balance during a Weekly Cycle of Hemodialysis.

Authors:  Jacek Waniewski; Malgorzata Debowska; Alicja Wojcik-Zaluska; Andrzej Ksiazek; Wojciech Zaluska
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

8.  Short- and Long-term Effects of Dialysate Calcium Concentrations on Mineral and Bone Metabolism in Hemodialysis Patients: The K4 Study.

Authors:  Teppei Sakoh; Masatomo Taniguchi; Shunsuke Yamada; Shotaro Ohnaka; Hokuto Arase; Masanori Tokumoto; Taihei Yanagida; Koji Mitsuiki; Hideki Hirakata; Toshiaki Nakano; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  Kidney Med       Date:  2019-09-11

9.  Dialysate Calcium: A Lot More Than 'Set It and Forget It'.

Authors:  Pranav S Garimella; Rakesh Malhotra
Journal:  Kidney Med       Date:  2019-09-12

10.  Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis.

Authors:  Satoshi Yamaguchi; Takayuki Hamano; Yohei Doi; Tatsufumi Oka; Sachio Kajimoto; Keiichi Kubota; Seiichi Yasuda; Karin Shimada; Ayumi Matsumoto; Nobuhiro Hashimoto; Yusuke Sakaguchi; Isao Matsui; Yoshitaka Isaka
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.